Novel variants in TUBA1A cause congenital fibrosis of the extraocular muscles with or without malformations of cortical brain development.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
05 2021
Historique:
received: 13 10 2020
accepted: 17 12 2020
revised: 12 12 2020
pubmed: 3 3 2021
medline: 18 1 2022
entrez: 2 3 2021
Statut: ppublish

Résumé

Variants in multiple tubulin genes have been implicated in neurodevelopmental disorders, including malformations of cortical development (MCD) and congenital fibrosis of the extraocular muscles (CFEOM). Distinct missense variants in the beta-tubulin encoding genes TUBB3 and TUBB2B cause MCD, CFEOM, or both, suggesting substitution-specific mechanisms. Variants in the alpha tubulin-encoding gene TUBA1A have been associated with MCD, but not with CFEOM. Using exome sequencing (ES) and genome sequencing (GS), we identified 3 unrelated probands with CFEOM who harbored novel heterozygous TUBA1A missense variants c.1216C>G, p.(His406Asp); c.467G>A, p.(Arg156His); and c.1193T>G, p.(Met398Arg). MRI revealed small oculomotor-innervated muscles and asymmetrical caudate heads and lateral ventricles with or without corpus callosal thinning. Two of the three probands had MCD. Mutated amino acid residues localize either to the longitudinal interface at which α and β tubulins heterodimerize (Met398, His406) or to the lateral interface at which tubulin protofilaments interact (Arg156), and His406 interacts with the motor domain of kinesin-1. This series of individuals supports TUBA1A variants as a cause of CFEOM and expands our knowledge of tubulinopathies.

Identifiants

pubmed: 33649541
doi: 10.1038/s41431-020-00804-7
pii: 10.1038/s41431-020-00804-7
pmc: PMC8110841
doi:

Substances chimiques

TUBA1A protein, human 0
Tubulin 0
Kinesins EC 3.6.4.4

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

816-826

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States
Organisme : CIHR
Pays : Canada
Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS007473
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY014104
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007748
Pays : United States
Organisme : NEI NIH HHS
ID : T32 EY007145
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027421
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY027850
Pays : United States

Références

Lasser M, Tiber J, Lowery LA. The role of the microtubule cytoskeleton in neurodevelopmental disorders. Front Cell Neurosci. 2018;12:165.
doi: 10.3389/fncel.2018.00165
Lopata MA, Cleveland DW. In vivo microtubules are copolymers of available beta-tubulin isotypes: localization of each of six vertebrate beta-tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens. J Cell Biol. 1987;105:1707–20.
doi: 10.1083/jcb.105.4.1707
Tilney LG, Bryan J, Bush DJ, Fujiwara K, Mooseker MS, Murphy DB, et al. Microtubules: evidence for 13 protofilaments. J Cell Biol. 1973;59:267–75.
doi: 10.1083/jcb.59.2.267
Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature. 1984;312:237–42.
doi: 10.1038/312237a0
Fulton C, Simpson P. Selective synthesis and utilization of flagellar tubulin. The multi-tubulin hypothesis. Cell Motil. 1976;3:987–1005.
Gonçalves FG, Freddi T de AL, Taranath A, Lakshmanan R, Goetti R, Feltrin FS, et al. Tubulinopathies. Topics Magn Reson Imaging. 2018;27:395–408.
doi: 10.1097/RMR.0000000000000188
Köhler S, Carmody L, Vasilevsky N, Jacobsen J, Danis D, Gourdine J, et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47:D1018–27.
doi: 10.1093/nar/gky1105
Engle EC, Goumnerov BC, McKeown CA, Schatz M, Johns DR, Porter JD, et al. Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol. 1997;41:314–25.
doi: 10.1002/ana.410410306
Demer JL, Clark RA, Engle EC. Magnetic Resonance Imaging Evidence For Widespread Orbital Dysinnervation in Congenital Fibrosis of Extraocular Muscles Due to Mutations in KIF21A. Invest Ophth Vis Sci. 2005;46:530–9.
doi: 10.1167/iovs.04-1125
Lim K, Engle E, Demer J. Abnormalities of the oculomotor nerve in congenital fibrosis of the extraocular muscles and congenital oculomotor palsy. Invest Ophth Vis Sci. 2007;48:1601–6.
doi: 10.1167/iovs.06-0691
Online Mendelian Inheritance in Man, OMIM. Mc-Kusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), accessed December 10, 2020. https://omim.org/
Yamada K, Andrews C, Chan W-M, McKeown CA, Magli A, Berardinis Tde, et al. Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat Genet. 2003;35:318–21.
doi: 10.1038/ng1261
Tischfield M, Baris H, Wu C, Rudolph G, Maldergem L, He W, et al. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell. 2010;140:74–87.
doi: 10.1016/j.cell.2009.12.011
Chew S, Balasubramanian R, Chan W, Kang P, Andrews C, Webb B, et al. A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain. 2013;136:522–35.
doi: 10.1093/brain/aws345
Cederquist GY, Luchniak A, Tischfield MA, Peeva M, Song Y, Menezes MP, et al. An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation. Hum Mol Genet. 2012;21:5484–99.
doi: 10.1093/hmg/dds393
Whitman MC, Andrews C, Chan W-M, Tischfield MA, Stasheff SF, Brancati F, et al. Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development. Am J Med Genet A. 2016;170A:297–305.
doi: 10.1002/ajmg.a.37362
Poirier K, Keays D, Francis F, Saillour Y, Bahi N, Manouvrier S, et al. Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha1A (TUBA1A). Hum Mutat. 2007;28:1055–64.
doi: 10.1002/humu.20572
Jaglin X, Poirier K, Saillour Y, Buhler E, Tian G, Bahi-Buisson N, et al. Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria. Nat Genet. 2009;41:746–52.
doi: 10.1038/ng.380
Poirier K, Saillour Y, Bahi-Buisson N, Jaglin X, Fallet-Bianco C, Nabbout R, et al. Mutations in the neuronal ß-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects. Hum Mol Genet. 2010;19:4462–73.
doi: 10.1093/hmg/ddq377
Latremoliere A, Cheng L, DeLisle M, Wu C, Chew S, Hutchinson EB, et al. Neuronal-specific TUBB3 is not required for normal neuronal function but is essential for timely axon regeneration. Cell Rep. 2018;24:1865–79.e9.
doi: 10.1016/j.celrep.2018.07.029
Bittermann E, Abdelhamed Z, Liegel R, Menke C, Timms A, Beier D, et al. Differential requirements of tubulin genes in mammalian forebrain development. Plos Genet. 2019;15:e1008243–e1008243.
doi: 10.1371/journal.pgen.1008243
Keays D, Tian G, Poirier K, Huang G-J, Siebold C, Cleak J, et al. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell. 2007;128:45–57.
doi: 10.1016/j.cell.2006.12.017
Furuse T, Yamada I, Kushida T, Masuya H, Miura I, Kaneda H, et al. Behavioral and neuromorphological characterization of a novel Tuba1 mutant mouse. Behavioural Brain Res. 2012;227:167–74.
doi: 10.1016/j.bbr.2011.11.002
Hanson MG, Aiken J, Sietsema DV, Sept D, Bates EA, Niswander L, et al. Novel α-tubulin mutation disrupts neural development and tubulin proteostasis. Dev Biol. 2016;409:406–19.
doi: 10.1016/j.ydbio.2015.11.022
Hebebrand M, Hüffmeier U, Trollmann R, Hehr U, Uebe S, Ekici A, et al. The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy. Orphanet J Rare Dis. 2019;14:38–38.
doi: 10.1186/s13023-019-1020-x
Nellhaus G. Head circumference from birth to eighteen years. Pediatrics. 1968;41:106–14.
doi: 10.1542/peds.41.1.106
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.
doi: 10.1093/bioinformatics/btp324
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.
doi: 10.1101/gr.107524.110
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17:122.
doi: 10.1186/s13059-016-0974-4
Beaulieu CL, Majewski J, Schwartzentruber J, Samuels ME, Fernandez BA, Bernier FP, et al. FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. Am J Hum Genetics. 2014;94:809–17.
doi: 10.1016/j.ajhg.2014.05.003
Paila U, Chapman BA, Kirchner R, Quinlan AR. GEMINI: integrative exploration of genetic variation and genome annotations. Plos Comput Biol. 2013;9:e1003153.
doi: 10.1371/journal.pcbi.1003153
Srour M, Schwartzentruber J, Hamdan F, Ospina L, Patry L, Labuda D, et al. Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population. Am J Hum Genetics. 2012;90:693–700.
doi: 10.1016/j.ajhg.2012.02.011
Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.
doi: 10.1038/nature19057
Karczewski K, Francioli L, Tiao G, Cummings B, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–43.
doi: 10.1038/s41586-020-2308-7
Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
doi: 10.1038/nature15393
Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–7.
doi: 10.1093/nar/gkx1153
Zhang R, Alushin GM, Brown A, Nogales E. Mechanistic origin of microtubule dynamic instability and its modulation by EB proteins. Cell. 2015;162:849–59.
doi: 10.1016/j.cell.2015.07.012
Gigant B, Wang W, Dreier B, Jiang Q, Pecqueur L, Plückthun A, et al. Structure of a kinesin–tubulin complex and implications for kinesin motility. Nat Struct Mol Biol. 2013;20:1001–7.
doi: 10.1038/nsmb.2624
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539–539.
doi: 10.1038/msb.2011.75
Waterhouse AM, Procter JB, Martin D, Clamp M, Barton GJ. Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–91.
doi: 10.1093/bioinformatics/btp033
Shoshany T, Robson C, Hunter D. Anomalous superior oblique muscles and tendons in congenital fibrosis of the extraocular muscles. J Am Assoc Pediatr Ophthalmol Strabismus. 2019;23:325.e1–325.e6.
doi: 10.1016/j.jaapos.2019.09.014
Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20:110–21.
doi: 10.1101/gr.097857.109
Rentzsch P, Witten D, Cooper G, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886–94.
doi: 10.1093/nar/gky1016
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–23.
doi: 10.1038/gim.2015.30
Samocha K, Robinson E, Sanders S, Stevens C, Sabo A, McGrath L, et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014;46:944–50.
doi: 10.1038/ng.3050
Nogales E, Whittaker M, Milligan RA, Downing KH. High-resolution model of the microtubule. Cell. 1999;96:79–88.
doi: 10.1016/S0092-8674(00)80961-7
Löwe J, Li H, Downing KH, Nogales E. Refined structure of αβ-tubulin at 3.5 Å resolution. J Mol Biol. 2001;313:1045–57.
doi: 10.1006/jmbi.2001.5077
Romaniello R, Zucca C, Arrigoni F, Bonanni P, Panzeri E, Bassi MT, et al. Epilepsy in tubulinopathy: personal series and literature review. Cells. 2019;8:669.
doi: 10.3390/cells8070669
Aiken J, Buscaglia G, Bates E, Moore J. The α-tubulin gene TUBA1A in brain development: a key ingredient in the neuronal isotype blend. J Dev Biol. 2017;5:8.
doi: 10.3390/jdb5030008
Romaniello R, Arrigoni F, Panzeri E, Poretti A, Micalizzi A, Citterio A, et al. Tubulin-related cerebellar dysplasia: definition of a distinct pattern of cerebellar malformation. Eur Radio. 2017;27:5080–92.
doi: 10.1007/s00330-017-4945-2

Auteurs

Julie A Jurgens (JA)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Brenda J Barry (BJ)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Gabrielle Lemire (G)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.

Wai-Man Chan (WM)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Mary C Whitman (MC)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Department of Ophthalmology, Boston Children's Hospital, Boston, MA, USA.
Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Sherin Shaaban (S)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Harvard Medical School, Boston, MA, USA.
Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.

Caroline D Robson (CD)

Division of Neuroradiology, Department of Radiology, Boston Children's Hospital, Boston, MA, USA.
Department of Radiology, Harvard Medical School, Boston, MA, USA.

Sarah MacKinnon (S)

Department of Ophthalmology, Boston Children's Hospital, Boston, MA, USA.
Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Eleina M England (EM)

Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.

Hugh J McMillan (HJ)

Division of Neurology, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

Christopher Kelly (C)

Pediatric Ophthalmology and Physician Informatics, MultiCare Health System, Tacoma, WA, USA.

Brandon M Pratt (BM)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Harvard Medical School, Boston, MA, USA.

Anne O'Donnell-Luria (A)

Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.

Daniel G MacArthur (DG)

Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Centre for Population Genomics, Garvan Institute of Medical Research and UNSW, Sydney, NSW, Australia.
Murdoch Children's Research Institute, Parkville, VIC, Australia.

Kym M Boycott (KM)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

David G Hunter (DG)

Department of Ophthalmology, Boston Children's Hospital, Boston, MA, USA.
Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Elizabeth C Engle (EC)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA. elizabeth.engle@childrens.harvard.edu.
Department of Neurology, Boston Children's Hospital, Boston, MA, USA. elizabeth.engle@childrens.harvard.edu.
Department of Neurology, Harvard Medical School, Boston, MA, USA. elizabeth.engle@childrens.harvard.edu.
Broad Institute of MIT and Harvard, Cambridge, MA, USA. elizabeth.engle@childrens.harvard.edu.
Howard Hughes Medical Institute, Chevy Chase, MD, USA. elizabeth.engle@childrens.harvard.edu.
Department of Ophthalmology, Boston Children's Hospital, Boston, MA, USA. elizabeth.engle@childrens.harvard.edu.
Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. elizabeth.engle@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH